- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01459120
Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho (DoDoPi)
Comparing Door-to-door Versus Community Gathering in Providing HIV Counseling and Testing Within an Integrated Primary Health Care Package: a Cluster Randomized Trial in Rural Lesotho
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
12 health centers (clusters) in rural Lesotho are matched according to their routine performance in VCT and enrollment into chronic HIV/AIDS care (average numbers tested positive and enrolled into HIV/AIDS care per month per facility). After matching, 6 health centers are randomly assigned to perform door-to-door VCT, whereas the others perform the traditional community gathering approach (called "pitso" in Sesotho). Within the catchment area of each health center five campaigns in five different, randomly selected villages, are held (one day VCT campaign per village). Within each cluster another five villages are randomly selected who do not get a particular campaign and serve as a control for each cluster. In each matched cluster-pair, both health centers conduct the five campaigns during the same week (one conducting it as door-to-door, the other one conducting it through "pitsos" (community gathering)).
Both approaches receive the same resources in terms of finances, time spending doing the VCT-campaign and human resources.
Typ studie
Zápis (Očekávaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
-
Thaba-Tseka, Lesotho
- Paray Hospital
-
-
Botha-Bothe
-
Seboche, Botha-Bothe, Lesotho, P.O. 304
- Seboche Hospital
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion criteria:
- Not already known to be HIV-positive
- Resident in the catchment area of the health center where the campaign is conducted
- Provision of written informed consent to participate (signed by writing or fingerprint)
- In case of children: Provision of written informed consent by an adult care-taker
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Výzkum zdravotnických služeb
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Door-to-Door
Health care workers propose the integrated service package including VCT at the peoples' homes.
|
Health workers propose the integrated service package including VCT at the peoples' homes (home-based testing).
|
|
Aktivní komparátor: Pitso
Health care workers propose the integrated service package including VCT through community gatherings ("pitso").
|
Health care workers propose the integrated service package including VCT through community gatherings ("Pitso").
|
|
Žádný zásah: control
Within each cluster (catchment area of a health center), five villages are randomly chosen as comparators on cluster level.
These villages get no particular intervention (VCT-campaign).
However, routine services continue to be provided.
These villages serve as a control for the third primary outcome that assesses the overall numbers newly enrolled into chronic HIV/AIDS care at facility-level.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Proportion of newly tested HIV-positive clients over all clients tested for HIV during the campaigns
|
Proportion refers to the proportion of newly tested HIV-positive clients among all clients tested for HIV during the voluntary counselling and testing campaigns in each arm.
|
|
|
Proportion of clients newly tested HIV-positive who enrolled into HIV/AIDS care within one month over all clients newly tested HIV-positive during the campaigns
Časové okno: 4 weeks after tested positive
|
One month after the campaigns, enrollment of clients who newly tested HIV-positive at the campaign is assessed at the facilities based on the clinics' registers.
|
4 weeks after tested positive
|
|
Overall number newly tested HIV-positive and enrolled into chronic HIV/AIDS-care at each facility
Časové okno: 4 weeks after campaign
|
Between the two study-arms, the overall numbers will be compared in two ways:
|
4 weeks after campaign
|
|
Absolute number of newly tested HIV-positive clients
|
Refers to the overall number newly tested HIV-positive during the campaigns in both arms
|
|
|
Absolute number of clients newly tested HIV-positive who enrolled into HIV/AIDS care
Časové okno: 4 weeks after tested HIV-positive
|
This refers to the absolute number newly tested HIV-positive during the campaigns who enrolled thereafter into chronic HIV/AIDS care within one month
|
4 weeks after tested HIV-positive
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
CD4-count among clients newly tested HIV-positive
|
CD4-counts will be measured on site using a Point-of-care machine.
|
|
|
Clinical WHO-stage among clients newly tested HIV-positive
|
||
|
Proportion of clients screened positive for Tuberculosis during the campaigns
|
All clients accessing services (irrespective of HIV-status) will be screened for TB by a nurse.
Clients with a positive screening are provided sputum bottles and are entered in the Tuberculosis-suspect register.
|
|
|
Proportion of first-time HIV-testers among all clients accessing the testing services
|
||
|
Proportion of clients with positive tuberculosis screening who return 3 sputum-bottles within ≤ 5 days to the facility
Časové okno: 5 days after the campaign was held
|
Tuberculosis-suspect registers and tuberculosis registers at the facility are used for verification
|
5 days after the campaign was held
|
|
Proportion of clients with a positive Tuberculosis-screening who return their sputum-bottles and who have at least one AFB-positive smear.
Časové okno: 5 days after the campaign was held
|
Tuberculosis suspect registers and Tuberculosis registers at the facility are used for verification.
|
5 days after the campaign was held
|
|
Demographic characteristics of clients accessing the voluntary counseling and testing services
|
||
|
Absolute number of clients accessing the services at the campaigns who have a positive screening for Tuberculosis
|
||
|
Absolute number of clients with positive tuberculosis screening who return 3 sputum-bottles within ≤ 5 days to the facility
Časové okno: ≤ 5 days after the campaigns
|
≤ 5 days after the campaigns
|
|
|
Absolute number of clients with a positive Tuberculosis-screening who return their sputum-bottles and who have at least one AFB-positive smear.
Časové okno: ≤ 5 days after the campaign
|
≤ 5 days after the campaign
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Motlomelo Masetsibi, SolidarMed
- Ředitel studie: Niklaus Labhardt, MD, MIH, SolidarMed
- Studijní židle: Karolin Pfeiffer, MD, McommH, SolidarMed
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
- Kardiovaskulární choroby
- Cévní onemocnění
- RNA virové infekce
- Virová onemocnění
- Infekce
- Infekce přenášené krví
- Přenosné nemoci
- Pohlavně přenosné choroby, virové
- Pohlavně přenosné nemoci
- Lentivirové infekce
- Retroviridae infekce
- Syndromy imunologické nedostatečnosti
- Onemocnění imunitního systému
- Bakteriální infekce
- Bakteriální infekce a mykózy
- Gram-pozitivní bakteriální infekce
- Infekce Actinomycetales
- Infekce Mycobacterium
- Pomalá virová onemocnění
- HIV infekce
- Hypertenze
- Tuberkulóza
- Syndrom získané immunití nedostatečnisti
Další identifikační čísla studie
- DoDoPi-1
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .